Suppr超能文献

溶酶体耗竭引发的自噬损伤在进行性肾损伤中的作用

Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury.

作者信息

Chen Xiao-Cui, Li Zhi-Hang, Yang Chen, Tang Ji-Xin, Lan Hui-Yao, Liu Hua-Feng

机构信息

Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

Kidney Dis (Basel). 2021 Jul;7(4):254-267. doi: 10.1159/000515035. Epub 2021 May 25.

Abstract

BACKGROUND

Macroautophagy (autophagy) is a cellular recycling process involving the destruction of damaged organelles and proteins in intracellular lysosomes for efficient nutrient reuse.

SUMMARY

Impairment of the autophagy-lysosome pathway is tightly associated with multiple kidney diseases, such as diabetic nephropathy, proteinuric kidney disease, acute kidney injury, crystalline nephropathy, and drug- and heavy metal-induced renal injury. The impairment in the process of autophagic clearance may induce injury in renal intrinsic cells by activating the inflammasome, inducing cell cycle arrest, and cell death. The lysosome depletion may be a key mechanism triggering this process. In this review, we discuss this pathway and summarize the protective mechanisms for restoration of lysosome function and autophagic flux via the endosomal sorting complex required for transport (ESCRT) machinery, lysophagy, and transcription factor EB-mediated lysosome biogenesis.

KEY MESSAGE

Further exploring mechanisms of ESCRT, lysophagy, and lysosome biogenesis may provide novel therapy strategies for the management of kidney diseases.

摘要

背景

巨自噬(自噬)是一种细胞循环过程,涉及在细胞内溶酶体中破坏受损细胞器和蛋白质以实现有效的营养物质再利用。

总结

自噬-溶酶体途径的损伤与多种肾脏疾病密切相关,如糖尿病肾病、蛋白尿性肾病、急性肾损伤、结晶性肾病以及药物和重金属诱导的肾损伤。自噬清除过程中的损伤可能通过激活炎性小体、诱导细胞周期停滞和细胞死亡来诱导肾固有细胞损伤。溶酶体耗竭可能是触发这一过程的关键机制。在本综述中,我们讨论了这一途径,并总结了通过运输所需的内体分选复合体(ESCRT)机制、溶酶体自噬和转录因子EB介导的溶酶体生物发生来恢复溶酶体功能和自噬通量的保护机制。

关键信息

进一步探索ESCRT、溶酶体自噬和溶酶体生物发生的机制可能为肾脏疾病的治疗提供新的策略。

相似文献

1
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury.
Kidney Dis (Basel). 2021 Jul;7(4):254-267. doi: 10.1159/000515035. Epub 2021 May 25.
2
ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival.
EMBO J. 2018 Nov 2;37(21). doi: 10.15252/embj.201899753. Epub 2018 Oct 12.
4
Repair or Lysophagy: Dealing with Damaged Lysosomes.
J Mol Biol. 2020 Jan 3;432(1):231-239. doi: 10.1016/j.jmb.2019.08.010. Epub 2019 Aug 23.
5
Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy.
Cancer Lett. 2024 Mar 1;584:216599. doi: 10.1016/j.canlet.2023.216599. Epub 2023 Dec 20.
6
Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity.
Arch Pharm Res. 2021 Jun;44(6):621-631. doi: 10.1007/s12272-021-01335-5. Epub 2021 Jun 7.
8
Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux.
Autophagy. 2021 Jul;17(7):1700-1713. doi: 10.1080/15548627.2020.1782034. Epub 2020 Jun 28.
9
How cells recognize and remove the perforated lysosome.
Autophagy. 2023 Jun;19(6):1869-1871. doi: 10.1080/15548627.2022.2138686. Epub 2022 Nov 11.
10
Regulation of lysosome integrity and lysophagy by the ubiquitin-conjugating enzyme UBE2QL1.
Autophagy. 2020 Jan;16(1):179-180. doi: 10.1080/15548627.2019.1687217. Epub 2019 Nov 6.

引用本文的文献

1
Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy.
Ren Fail. 2025 Dec;47(1):2543927. doi: 10.1080/0886022X.2025.2543927. Epub 2025 Aug 19.
3
Cathepsin B induces kidney diseases through different types of programmed cell death.
Front Immunol. 2025 Mar 10;16:1535313. doi: 10.3389/fimmu.2025.1535313. eCollection 2025.
4
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non-diabetic veterinary patients with cardiac and kidney diseases?
J Vet Pharmacol Ther. 2025 Jan;48 Suppl 1(Suppl 1):1-18. doi: 10.1111/jvp.13472. Epub 2024 Jul 13.
5
Proteomic Changes Induced by the Immunosuppressant Everolimus in Human Podocytes.
Int J Mol Sci. 2024 Jul 4;25(13):7336. doi: 10.3390/ijms25137336.
6
PRKAA2, MTOR, and TFEB in the regulation of lysosomal damage response and autophagy.
J Mol Med (Berl). 2024 Mar;102(3):287-311. doi: 10.1007/s00109-023-02411-7. Epub 2024 Jan 6.
7
knockout protects against renal fibrosis by restraining the CN‑NFAT2 signaling pathway in T2DM mice.
Mol Med Rep. 2024 Jan;29(1). doi: 10.3892/mmr.2023.13136. Epub 2023 Dec 1.
8
Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis.
Cell Death Dis. 2023 Aug 29;14(8):571. doi: 10.1038/s41419-023-06093-4.
9
Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology.
Front Cell Neurosci. 2023 Mar 16;17:1086895. doi: 10.3389/fncel.2023.1086895. eCollection 2023.

本文引用的文献

1
SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy.
Autophagy. 2021 Sep;17(9):2325-2344. doi: 10.1080/15548627.2020.1824694. Epub 2020 Oct 12.
2
Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance-A Mini Review.
Front Oncol. 2020 Jul 9;10:1156. doi: 10.3389/fonc.2020.01156. eCollection 2020.
4
Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury.
Theranostics. 2020 Apr 27;10(13):5829-5844. doi: 10.7150/thno.44051. eCollection 2020.
5
Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.
Cell Death Discov. 2020 May 1;6:32. doi: 10.1038/s41420-020-0265-4. eCollection 2020.
6
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer.
Cell Death Discov. 2020 Mar 11;6:12. doi: 10.1038/s41420-020-0246-7. eCollection 2020.
7
Lysosome biology in autophagy.
Cell Discov. 2020 Feb 11;6:6. doi: 10.1038/s41421-020-0141-7. eCollection 2020.
8
Tizoxanide induces autophagy by inhibiting PI3K/Akt/mTOR pathway in RAW264.7 macrophage cells.
Arch Pharm Res. 2020 Feb;43(2):257-270. doi: 10.1007/s12272-019-01202-4. Epub 2020 Jan 1.
9
Blocking AMPK/ULK1-dependent autophagy promoted apoptosis and suppressed colon cancer growth.
Cancer Cell Int. 2019 Dec 13;19:336. doi: 10.1186/s12935-019-1054-0. eCollection 2019.
10
Lysosomal size matters.
Traffic. 2020 Jan;21(1):60-75. doi: 10.1111/tra.12714. Epub 2019 Dec 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验